Lighting the Way to a Cure

  • Financials
  • Patient Library
  • Blog
  • Calendar
FSHD Header Logo
mobile-logo

  • Who We Are
        • About Us
          • History
          • Mission
          • Our Team
        • Our Impact
          • Therapeutic Accelerator
          • Education
          • Advocacy
          • Our Partners
        • Journey To A Cure
          • 2022 Donor Impact Report
  • Understanding FSHD
        • What is FSHD
          • Symptoms
          • Diagnosis
          • Early-onset FSHD
          • Genetic Testing
        • Living with FSHD
          • Newly Diagnosed?
          • Finding Care
          • Symptom Management
          • Patient Library
        • FSHD University
          • Physical Health
          • Wellness
          • Research
  • Get Involved
        • Support Us
          • Ways to Give
          • Become a Torchbearer
          • Raise Awareness
          • Volunteer
          • Fundraise
        • Advance Research
          • Patient Involvement
          • True Cost of FSHD Study
          • Clinical Trials
          • Donate tissue
        • Connect
          • Find Your Local Chapter
          • Join the Community
          • World FSHD Alliance
          • Online Communities
        • Events
          • Walk & Roll to Cure FSHD
          • Events Calendar
          • FSHD 360 Regional Conferences
          • FSHD Connect Conference
  • Research
        • For Patients & Families
          • Advance Research
          • True Cost of FSHD Study
          • TestFSHD genetic testing
          • Clinical Trials
        • For Researchers
          • Apply for a Grant
          • Research We Have Funded
          • Resources
          • Int’l Research Congress
        • For Clinicians
          • FSHD Masterclass
          • ICD-10
        • Global Collaboration
          • Therapeutic Accelerator
          • Clinical Trial Research Network
          • Drug Development Pipeline
          • Project Mercury
  • News
    • Media Library
    • Blog
      • Living with FSHD
        • Health and Medicine
        • PT and Exercise
        • Tips and Tricks
        • Mental Health
      • FSHD Society News
      • FSHD Research
      • Fundraising & Events
      • Media & PR
    • FSHD Society Radio
    • The FSHD Advocate
  • JOIN US
  • Donate
  • JOIN US
  • Donate

GE Chairman’s Award Benefits FSH Muscular Dystrophy Research

Home / Fundraising & Events / GE Chairman’s Award Benefits FSH Muscular Dystrophy Research

Posted on: Mar 03, 2014

When GE Aviation’s Vice President Mohammad Ehteshami was told that he had received the prestigious GE Chairman’s Award, he asked that the $25,000 be donated to the FSH Society, a Massachusetts-based charitable foundation that has transformed the science of a little-known disease, facioscapulohumeral muscular dystrophy (FSHD).

“FSHD has impacted someone very dear to me, and I therefore wanted to do my part in helping to fund the research for finding a cure,” Ehtashami told the FSH Society.

FSHD is one of the most common muscle dystrophies. The genetic disorder typically attacks the muscles of the face (facio), shoulder blades (scapula) and arms (humerus), but can progress to affect all skeletal muscles. Approximately one-quarter to one-third of patients end up in wheelchairs. FSHD affects more than half a million people around the world.

Every year, GE Chairman of the Board and CEO Jeff Immelt recognizes leaders from across the company with the annual Chairman’s Awards for their outstanding performance and leadership. Those who receive the Chairman’s Award have the honor of selecting a non-profit of their choice to receive a $25,000 monetary donation from GE.

This year, Ehteshami, who is Vice President for New Product Introduction Engineering Operations at GE Aviation, was recognized for his domain expertise and technology leadership in 2013.

“We congratulate Mr. Ehtashami on the recognition he has received from his company and are deeply honored that he chose the FSH Society to receive this generous donation,” said FSH Society Executive Director June Kinoshita. “FSHD is among the most prevalent muscular dystrophies, but is little known to the public, so corporate philanthropy is immensely important in helping to raise awareness and much-needed funds.”

Share

Filed Under: Fundraising & Events, Media & PR

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH

Categories

  • FSHD Research
  • FSHD Society News
    • Extraordinary Measures
    • Journey to a Cure
  • Fundraising & Events
  • General
  • Living with FSHD
    • Health and Medicine
    • Mental Health
    • PT and Exercise
    • Tips and Tricks
  • Media & PR

Sign up for Email Alerts

Stay up to date with the latest FSHD news and updates from FSHD Society.

CONNECT WITH US

Proud Member World FSHD Alliance (1)
Footer-Logo-min

General Mailing Address:

75 North Main Street, Suite 1073
Randolph, MA 02368 U.S.A.

Mail Donations to:

Department 960
PO Box 4106
Woburn, MA 01888-4106

(781) 301-6060

  • DONATE
  • Donate
  • Join Us
  • Inclusivity & Equity
  • Privacy Policy
  • Contact Us
  • Glossary Of Scientific Terms
Digital Marketing by